Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma

Thyroid

Volumn 17, Issue 5, 2007, Pages 389-393

  Ugolini, Clara ^a   Basolo, Fulvio ^a,c   Proietti, Agnese ^a   Vitti, Paolo ^a   Elisei, Rossella ^a   Miccoli, Paolo ^a   Toniolo, Antonio ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c Division of Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

T6 ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADULT; AGED; ANTIGENS, CD1; ANTIGENS, CD20; DENDRITIC CELLS; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; THYROID NEOPLASMS;

EID: 34249937031     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0306     Document Type: Article

References (16)

1. Modi J, Patel A, Terrell R, Tuttle RM, Francis GL 2003 Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes. J Clin Endocrinol Metab 88:4418-4425.
2. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tamai H 1995 The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 80:3421-3424.
3. Gupta S, Patel A, Folstad A, Fenton C, Dinauer CA, Tuttle RM, Conran R, Francis GL 2001 Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab 86:1346-1354.
4. Tsuge K, Takeda H, Kawada S, Maeda K, Yamakawa M 2005 Characterization of dendritic cells in differentiated thyroid cancer. J Pathol 205:565-576.
5. Bachleitner-Hofmann T, Stift A, Friedl J, Pfragner R, Radelbauer K, Dubsky P, Schuller G, Benko T, Niederle B, Brostjan C, Jakesz R, Gnant M 2006 Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells. J Clin Endocrinol Metab 87:1098-1104.
6. Schott M, Seissler J 2003 Dendritic cell vaccination: new hope for the treatment of metastasized endocrine malignancies. Trends Endocrinol Metab 14:156-162.
7. Stift A, Sachet M, Yagubian R, Bittermann C, Dubsky P, Brostjan C, Pfragner R, Niederle B, Jakesz R, Gnant M, Friedl J 2004 Dendritic cell vaccination in medullary thyroid carcinoma. Clin Cancer Res 10:2944-2953.
8. Yang L, Carbone DP 2004 Tumor-host immune interactions and dendritic cell dysfunction. Adv Cancer Res 92:13-27.
9. Mende I, Engleman EG 2005 Breaking tolerance to tumors with dendritic cell-based immunotherapy. Ann N Y Acad Sci 1058:96-104.
10. Shortman K, Liu YJ 2002 Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151-161.
11. Coventry B, Heinzel S 2004 CD1a in human cancers: a new role for an old molecule. Trends Immunol 25:242-248.
12. Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, Guastalla JP, Bremond A, Goddard S, Pin JJ, Barthelemy-Dubois C, Lebecque S 2004 Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 15:7466-7474.
13. Dadabayev AR, Sandel MH, Menon AG, Morreau H, Melief CJ, Offringa R, van der Burg SH, Janssen-van Rhijn C, Ensink NG, Tollenaar RA, van de Velde CJ, Kuppen PJ 2004 Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother 53:978-986.
14. Batistatou A, Zolota V, Scopa CD 2002 S-100 protein+ dendritic cells and CD34+ dendritic interstitial cells in thyroid lesions. Endocr Pathol 13:111-115.
15. Thompson LD, Wieneke JA, Heffess CS 2005 Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases. Endocr Pathol 16:331-348.
16. Haq M, Harmer C 2005 Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol 63:87-93.